MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-14-2026
Koninklijke Philips N.V. Cash Conversion Cycle 2011-2026 | PHG
Annual Cash Conversion Cycle Koninklijke Philips N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 89 | 87.9 | 91.7 | 86.7 | 82.9 | 95 |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 95 | 82.9 | 88.9 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Biomerica
BMRA
|
172 | $ 2.13 | - | $ 4.89 M |  USA |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
299 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
Lantheus Holdings
LNTH
|
97.3 | $ 74.43 | -1.72 % | $ 5.02 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 158.47 | 0.24 % | $ 7.85 B | USA |
 |
IQVIA Holdings
IQV
|
73.9 | $ 165.48 | -0.92 % | $ 28.4 B | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 457.54 | 0.13 % | $ 13.2 B | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
166 | $ 1.21 | -17.14 % | $ 6.59 M | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 243.86 | 0.28 % | $ 25.6 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
44.9 | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
IDEXX Laboratories
IDXX
|
103 | $ 571.85 | -1.15 % | $ 46 B | USA |
 |
Illumina
ILMN
|
142 | $ 125.07 | 1.03 % | $ 19.9 B | USA |
 |
ICON Public Limited Company
ICLR
|
62 | $ 100.54 | 0.19 % | $ 8.29 B |  Irlanda |
 |
Myriad Genetics
MYGN
|
49.3 | $ 4.68 | 0.54 % | $ 433 M | USA |
 |
Guardant Health
GH
|
79.6 | $ 83.91 | -1.17 % | $ 10.5 B | USA |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B |  Niderland |
 |
National Research Corporation
NRC
|
29.4 | $ 17.51 | - | $ 392 M | USA |
 |
Pacific Biosciences of California
PACB
|
185 | $ 1.36 | -2.52 % | $ 408 M | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 263.49 | -0.37 % | $ 21.9 B | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Precipio
PRPO
|
-3.19 | $ 26.85 | -0.3 % | $ 34.8 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-1.24 K | $ 3.41 | -2.16 % | $ 1.83 M | USA |
 |
NeoGenomics
NEO
|
82.4 | $ 7.93 | -2.1 % | $ 1.02 B | USA |
 |
Personalis
PSNL
|
-11.5 | $ 7.52 | -1.18 % | $ 446 M | USA |
 |
Natera
NTRA
|
81.5 | $ 194.93 | -2.58 % | $ 19.2 B | USA |
 |
RadNet
RDNT
|
34.5 | $ 59.45 | -3.72 % | $ 4.47 B | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 17.37 | -1.08 % | $ 926 M | USA |
 |
OPKO Health
OPK
|
242 | $ 1.14 | -1.3 % | $ 791 M | USA |
 |
Castle Biosciences
CSTL
|
45.9 | $ 25.36 | -1.51 % | $ 704 M | USA |
 |
Senseonics Holdings
SENS
|
36.1 | $ 6.71 | 1.36 % | $ 280 M | USA |
 |
Sotera Health Company
SHC
|
33.5 | $ 13.8 | -0.61 % | $ 3.92 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 195.47 | -0.08 % | $ 21.7 B | USA |
 |
DarioHealth Corp.
DRIO
|
115 | $ 7.37 | -1.73 % | $ 29.4 M | Israel |
 |
DexCom
DXCM
|
134 | $ 66.5 | 0.85 % | $ 25.9 B | USA |